ANI Pharmaceuticals ANIP Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ANI Pharmaceuticals's deferred tax assets and other non-current assets?
- ANI Pharmaceuticals (ANIP) reported deferred tax assets and other non-current assets of $11.58M in Q1 2026.
- How has ANI Pharmaceuticals's deferred tax assets and other non-current assets changed year-over-year?
- ANI Pharmaceuticals's deferred tax assets and other non-current assets increased by 12.2% year-over-year, from $10.31M to $11.58M.
- What is the long-term trend for ANI Pharmaceuticals's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), ANI Pharmaceuticals's deferred tax assets and other non-current assets has grown at a 76.4% compound annual growth rate (CAGR), from $802K to $13.71M.